Eszopiclone for lowering blood pressure in adults with insomnia and high blood pressure
Official title: Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN)
Run by University of Sao Paulo · NCT07018557 · Data updated 2026-11-12
This study tests whether eszopiclone can improve sleep and lower 24-hour ambulatory blood pressure in adults aged 30–75 who have insomnia and treated hypertension.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 30 Years to 75 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University of Sao Paulo Academic / other |
| Locations | 1 site (São Paulo, São Paulo) |
| Status | Recruiting |
| Started | June 4, 2025 |
| Main results expected | June 1, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | June 12, 2025 |
| Trial ID | NCT07018557 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 30–75 years old with treated high blood pressure (systolic 130–160 mmHg, diastolic 80–100 mmHg), BMI <40 kg/m2, and insomnia who can attend clinic visits and are not using benzodiazepines or 'Z' drugs are ideal candidates.
✕Probably not a fit
Patients with severe COPD, heart failure with reduced ejection fraction, prior stroke, severe psychiatric disorders, advanced kidney disease, decompensated diabetes, active cancer, pregnancy, current benzodiazepine/'Z' drug use, or shift work are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with treated hypertension will be screened for insomnia and undergo baseline questionnaires and portable sleep apnea monitoring. After a one‑month run‑in period to confirm adherence and baseline blood pressure, eligible participants will be randomized in a double‑blind fashion to sleep hygiene plus eszopiclone 3 mg or sleep hygiene plus placebo for three months. The primary outcome is change in 24‑hour ambulatory blood pressure, with secondary outcomes including daytime/nighttime BP changes, non‑dipping status, office BP, and multiple validated sleep and mood scales. Demographic, anthropometric, comorbidity, and medication data will also be collected at baseline and after three months.
Why it matters
Potential benefit: If successful, this could offer a way to improve sleep and modestly reduce 24‑hour blood pressure in patients with insomnia and hypertension.
How similar studies have gone: Observational studies link insomnia to higher blood pressure, but randomized double‑blind trials testing hypnotic medications like eszopiclone on 24‑hour ambulatory blood pressure are limited, so this approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (30 to 75 years-old) * BMI \<40Kg/m2; * Availability to participate * History of HBP under regular treatment (systolic pressure between 130-160 and diastolic pressure between 80-100 mmHg). Exclusion Criteria: * Use of benzodiazepines or "Z" drugs; * Night workers; * History of severe chronic obstructive pulmonary disease (COPD); * Heart failure (ejection fraction \<40% on echocardiogram); * Prior stroke; * Generalized anxiety disorder (GAD-7 \>14 points) and severe depression (Beck); * Severe liver disease; * Alcohol abuse; * Advanced chronic kidney disease 4 or 5 (glomerular filtration rate \<30ml/min/1.73m2); * Patient who is on loop diuretics; * Patient with type 1 diabetes; * Patient with decompensated type 2 diabetes (Glycated hemoglobin \>10%); * Urinuria Incontinence; * Prostatism; * History of active cancer; * Pregnancy; * Complex sleep behaviors, suicidal behavior.
Where it's running
-
Academic Research Organization - Heart Institute (InCor)
São Paulo, São Paulo, Brazil Recruiting
Study contacts
- Study coordinator: LUCIANO F DRAGER, MD, PhD
- Email: luciano.drager@incor.usp.br
- Phone: +5511988027887
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sleep and arterial function in hypertensive patients with poor sleep quality
This trial tests whether using cognitive-behavioural therapy for insomnia can improve artery health and well-being in adults with high blood pressure and poor sleep.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Understanding how drugs work in children
This study is trying to find the best and safest doses of certain medications for children and young adults under 21 who are being treated for conditions like COVID-19 and pulmonary arterial hypertension.
-
SleepCogni for children with chronic insomnia
A handheld SleepCogni device is tested to see if it helps kids aged 6–16 with chronic insomnia sleep better.
-
Music therapy after stroke
This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.